دبلوماسية

Covid-19: EU states to resume AstraZeneca vaccine rollout

The EU’s leading states are to restart their roll-out of the Oxford-AstraZeneca Covid-19 vaccine after Europe’s medicines regulator concluded it was “safe and effective”.

The European Medicines Agency (EMA) reviewed the jab after 13 European countries suspended use of the vaccine over fears of a link to blood clots.

It found the jab was “not associated” with a higher risk of clots.

Germany, France, Italy and Spain said they would resume using the jab.

It is up to individual EU states to decide whether and when to re-start vaccinations using the AstraZeneca vaccine. Sweden said it needed a “few days” to decide.

  • Oxford-AstraZeneca vaccine safe, says PM
  • Is the Oxford-AstraZeneca vaccine safe?
  • Is Europe’s AstraZeneca jab decision-making flawed?
  • How will we know Covid vaccines are safe?

The World Health Organization (WHO) on Thursday called on countries to continue using the vaccine, and is due to release the results of its own review into the vaccine’s safety on Friday.

The agency’s investigation focused on a small number of cases of unusual blood disorders. In particular, it was looking at cases of cerebral venous thrombosis – blood clots in the head.

Decisions to suspend use of the vaccine sparked concerns over the pace of the region’s vaccination drive, which had already been affected by supply shortages.

French Prime Minister Jean Castex announced new measures for his country on Thursday, saying the pandemic was clearly accelerating and a “third wave” of infections looked increasingly likely.

  • Paris to lock down as France fears ‘third wave’

Mr Castex, 55, said he would receive the jab himself on Friday afternoon.

Share this post:

Share on facebook
Share on twitter
Share on pinterest

Leave a Reply

Your email address will not be published.